Health Care

Novavax stock tanks on report of COVID-19 vaccine manufacturing troubles

The potential production problems with Novavax's vaccine could hamper the efforts of the COVAX initiative, which forecast in September that it will be able to provide low and middle-income countries 1.425 billion COVID-19 vaccine doses to by the end of the year and 2 billion doses by the first quarter of 2022.

At-home COVID-19 tests recalled over false positives

Hundreds of thousands of at-home COVID-19 tests from Australia-based digital diagnostics company Ellume were recalled Tuesday after discovering that some tests delivered higher-than-expected false positive results.

Merck to request emergency approval for COVID-19 antiviral pill

Merck will request emergency approval for an experimental oral COVID-19 antiviral drug, molnupiravir, after a late-stage trial indicated an approximate 50% risk reduction for hospitalization or death among patients with mild to moderate COVID-19.